Otolaryngeal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-03-19
Clinical Trial Update: Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients [Phase 4]
Phase 4 trial assessing delirium prevention with ketamine in ENT cancer patients was terminated; results posted in 2021.